Search Results - "DELTACCA, Mario"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

    Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients by TIBALDI, Carmelo, GIOVANNETTI, Elisa, PETERS, Godefridus J, FALCONE, Alfredo, DANESI, Romano, MEY, Enricovasile Valentina, LAAN, Adrie C, NANNIZZI, Sara, DI MARSICO, Roberta, ANTONUZZO, Andrea, ORLANDINI, Cinzia, RICCIARDI, Simona, DELTACCA, Mario

    Published in Clinical cancer research (15-03-2008)
    “…Purpose: Selecting patients according to key genetic characteristics may help to tailor chemotherapy and optimize the treatment in non–small cell lung cancer…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Linezolid in the central nervous system: Comparison between cerebrospinal fluid and plasma pharmacokinetics

    Linezolid in the central nervous system: Comparison between cerebrospinal fluid and plasma pharmacokinetics by Viaggi, Bruno, Paolo, Antonello Di, Danesi, Romano, Polillo, Marialuisa, Ciofi, Laura, Tacca, Mario Del, Malacarne, Paolo

    “…Abstract Background: Linezolid is effective against methicillin-resistant Staphylococcus aureus, which may cause central nervous system (CNS) infections, but…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: